VA
ZURA icon

Verdad Advisers’s Zura Bio ZURA Stock Holding History

Verdad Advisers’s Portfolio ZURA Stock Details ZURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$395K Sell
66,919
-30,183
-31% -$144K 0.38% 97
2026
Q1 		$578K Buy
+97,102
New +$587K 0.65% 51

Other funds holding ZURA

SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.64B AUM 245.64% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Verdad Advisers's ZURA Position: Q2 2026 in Review

Verdad Advisers reduced its Zura Bio (ZURA) stake by 31% in Q2 2026, selling an estimated $144K and leaving 66,919 shares worth $395K. The position accounts for 0.38% of the portfolio, ranked #97.

Verdad Advisers first reported a position in ZURA in Q1 2026 and has held it in 2 quarters since. The position peaked at $578K in Q1 2026. 95 funds tracked by Wall St. Rank hold ZURA as of Q2 2026.

  • Verdad Advisers held 66,919 shares of Zura Bio worth $395K as of Q2 2026.
  • Verdad Advisers sold 30,183 Zura Bio shares in Q2 2026, an estimated $144K.
  • Zura Bio made up 0.38% of Verdad Advisers's portfolio in Q2 2026, its #97 holding.
  • Verdad Advisers first reported a position in Zura Bio in Q1 2026 and has held it in 2 quarters since.
  • Verdad Advisers's Zura Bio position peaked at $578K in Q1 2026.
  • 95 funds tracked by Wall St. Rank held Zura Bio as of Q2 2026.

Based on Verdad Advisers's 13F filing for Q2 2026, filed 14 Aug 2026.